A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
GMFH to take part in the 21st International Congress of Nutrition (ICN)
18 Sep 2017by GMFH Editing Team
Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).
The contributions of gut microbiota and probiotics to gut motility and constipation
27 Jul 2017by Andreu Prados
A recent study explored the extent to which transit time could affect gut microbiota composition and metabolism, using a multi-compartmental in vitro continuous culture system simulating the physiological conditions of the proximal, transversal, and distal parts of the colon.
New insights on how altered gut microbiota mediates some of metformin’s therapeutic effects
24 Jul 2017by Andreu Prados
A new randomized, placebo-controlled, double-blind study has found both clinical and mechanistic evidence that metformin’s improved blood glucose control is achieved through modulation of the gut microbiota.
Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
New systematic review identifies the need for better reporting of key methodological components of FMT interventions
6 Jul 2017by Andreu Prados
A recent systematic review has examined how all published studies assessing FMT were conducted and reported, particularly focusing on whether the studies adequately described the main methodological components of the FMT intervention.
A new study on the mechanisms involved in recovery from recurrent Clostridium difficile infection after faecal microbiota transplantation
5 Jun 2017by Andreu Prados
A new study has found that engraftment of a donor’s gut microbial community is not necessary for recovery from recurrent C. difficile infection after faecal microbiota transplantation.
Researchers find the first evidence of brain structural alterations correlated with gut microbes in people with irritable bowel syndrome
29 May 2017by Andreu Prados
A new study has found that gut microbial composition may be associated with brain structural alterations in people with IBS.
A recent randomised placebo-controlled trial, led by Prof. Thomas Borody from the Centre for Digestive Diseases in Sydney (Australia), has found that faecal microbiota transplantation induces clinical remission and endoscopic improvement in patients with active ulcerative colitis.
Heritable faecal microbes in humans are associated with abdominal adiposity
30 Jan 2017by Andreu Prados
A recent cross-sectional study, led by Prof. Tim Spector and Dr. Jordana Bell from the Department of Twin Research & Genetic Epidemiology at King’s College London (United Kingdom), has found that the human faecal microbiome is related to abdominal adiposity.
